Estrogen and hippocampal plasticity in rodent models

Journal of Alzheimer's Disease

Volumn 15, Issue 4, 2008, Pages 589-603

  Foy, Michael R ^a   Baudry, Michel ^b   Diaz Brinton, Roberta ^b   Thompson, Richard F ^b  

^a LOYOLA MARYMOUNT UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

3xTg AD; Aging; Estrogen; Hippocampus; LTP; Mouse; Synaptic plasticity

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 6,7 DINITRO 2,3 QUINOXALINEDIONE; AMPA RECEPTOR; AMYLOID BETA PROTEIN; CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; GESTAGEN; HORMONE; MUSCARINIC RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NIFEDIPINE; RALOXIFENE; TAU PROTEIN;

AGING; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; BRAIN CORTEX; CELL PROTECTION; COGNITION; COMPREHENSION; DRUG EFFECT; DRUG MEGADOSE; ESTROGEN THERAPY; HIPPOCAMPUS; HORMONAL REGULATION; HORMONAL THERAPY; HUMAN; LEARNING; LONG TERM POTENTIATION; MEMORY; MENOPAUSAL SYNDROME; MENTAL TASK; MOUSE; NERVE CELL PLASTICITY; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; OVARIECTOMY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECALL; REPRODUCTION; REVIEW; SENILE PLAQUE; SYNAPTIC TRANSMISSION; TRANSGENIC MOUSE; VERBAL MEMORY;

EID: 58149400495     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2008-15406     Document Type: Review

References (126)

1. G. Akopian, M.R. Foy and R.F. Thompson, 17B-estradiol enhancement of LTP involves activation of voltage-dependent calcium channels, Soc Neurosci Abstr (2003), Program No. 255.252.
2. S. Asthana, L.D. Baker, S. Craft, F.Z. Stanczyk, R.C. Veith, M.A. Raskind and S.R. Plymate, High-dose estradiol improves cognition for women with AD: results of a randomized study, Neurology 57 (2001), 605-612.
3. T. Backstrom, Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle, Acta Neurol Scand 54 (1976), 321-347.
4. C.A. Barnes, Memory deficits associated with senescence: a neurophysiological and behavioral study in the rat, J Comp Physiol Psychol 93 (1979), 74-104.
5. C.A. Barnes, G. Rao, T.C. Foster and B.L. McNaugton, Region-specific age effects on AMPA sensitivity: electrophysiological evidence for loss of synaptic contacts in hippocampal field CA1, Hippocampus 2 (1992), 457-468.
6. C.A. Barnes, Normal aging: regionally specific changes in hippocampal synaptic transmission, Trends Neurosci 17 (1994), 13-18.
7. E. Barrett-Conner and D. Kritz-Silverstein, Estrogen replacement therapy and cognitive function in older women, JAMA 269 (1993), 2637-2641.
8. M. Baudry, J.L. Davis and R.F. Thompson, Advances in Synaptic Plasticity, The MIT Press, Cambridge, MA, 2000.
9. M.F. Bear and R.C. Malenka, Synaptic plasticity: LTP and LTD, Curr Opin Neurobiol 4 (1994), 389-399.
10. D.E. Berman, S. Hazvi, K. Rosenblum and R.Y.D. Seger, Specific and differential activation of mitogen-activated protein kinase cascades by unfamiliar taste in the insular cortex of the behaving rat, J Neurosci 18 (1998), 10037-10044.
11. B. Berry, R. McMahan and M. Gallagher, Spatial learning and memory at defined points of the estrous cycle: effects on performance of a hippocampal-dependent task, Behav Neurosci 111 (1997), 267-274.
12. G.Q. Bi and M.M. Poo, Synaptic modification by correlated activity: Hebb's postulate revisited, Ann Rev Neurosci 24 (2001), 139-166.
13. R. Bi, G. Broutman, M. Foy, R.F. Thompson and M. Baudry, The tyrosine kinase and MAP kinase pathways mediate multiple effects of estrogen in hippocampus, Proc Natl Acad Sci USA 97 (2000), 3602-3607.
14. R. Bi, M.R. Foy, R.M. Vouimba, R.F. Thompson and M. Baudry, Cyclic changes in estradiol regulate synaptic plasticity through the MAP kinase pathway, Proc Natl Acad Sci USA 98 (2001), 13391-13395.
15. L.M. Billings, S. Oddo, K.N. Green, J.L. McGaugh and F.M. LaFerla, Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice, Neuron 45 (2005), 675-688.
16. H.A. Bimonte-Nelson, R.S. Singleton, C.L. Hunter, K.L. Price, A.B. Moore and A.C. Granholm, Ovarian hormones and cognition in the aged female rat: I. Long-term, but not short-term, ovariectomy enhances spatial performance, Behav Neurosci 117 (2003), 1395-1406.
17. H.A. Bimonte-Nelson, R.S. Singleton, B.J. Williams and A.C. Granholm, Ovarian hormones and cognition in the aged female rat: II. progesterone supplementation reverses the cognitive enhancing effects of ovariectomy, Behav Neurosci 118 (2004), 707-714.
18. T.V.P. Bliss and G.L. Collingridge, Asynaptic model of memory: long-term potentiation in the hippocampus, Nature 361 (1993), 31-39.
19. S. Blum, A.N. Moore, F. Adams and P.K. Dash, A mitogen-activated protein kinase cascade in the CA1/CA2 subfield of the dorsal hippocampus is essential for long-term spatial memory, J Neurosci 19 (1999), 3535-3544.
20. R. Brambilla, N. Gnesutta, L. Minichiello, G. White, A.J. Roylance, C.E. Herron, M. Ramsey, D.P. Wolfer, V. Cestari, C. Rossi-Arnaud, S.G. Grant, P.F. Chapman, H.P. Lipp, E. Sturani and R. Klein, A role for the Ras signaling pathway in synaptic transmission and long-term memory, Nature 290 (1997), 281-286.
21. R.D. Brinton, P. Proffitt, J. Tran and R. Luu, Equilin, a principal component of the estrogen replacement therapy, premarin, increases the growth of cortical neurons via an NMDA receptor dependent mechanism, Exp Neurol 147 (1997), 211-220.
22. R.D. Brinton, J. Tran, P. Proffitt and M. Kihil, 17B-estradiol increases the growth and survival of cultured cortical neurons, Neurochemical Research 22 (1997), 1339-1351.
23. R. Brookmeyer, S. Gray and C. Kawas, Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset, Am J Public Health 88 (1998), 1337-1342.
24. L.W. Campbell, S.Y. Hao, O. Thibault, E.M. Blalock and P.W. Landfield, Aging changes in voltage-gated calcium currents in hippocampal CA1 neurons, J Neurosci 16 (1996), 6286-6295.
25. J.C. Carroll, E.R. Rosario, L. Chang, F.Z. Stanczyk, S. Oddo, F.M. LaFerla and C.J. Pike, Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice, J Neurosci 27 (2007), 13357-13365.
26. I. Cavus and T.J. Teyler, Two forms of long-term potentiation in area CA1 activate different signal transduction cascades, J Neurophysiol 76 (1996), 3038-3047.
27. L.K. Clinton, L.M. Billings, K.N. Green, A. Caccamo, J. Ngo, S. Oddo, J.L. McGaugh and F.M. LaFerla, Age-dependent sexual dimorphism in cognition and stress re sponse in the 3xTg-AD mice, Neurobiol Dis 28 (2007), 76-82.
28. D.A. Cordoba Montoya and H.F. Carrer, Estrogen facilitates induction of long term potentiation in the hippocampus of awake rats, Brain Res 778 (1997), 430-438.
29. J. Couzin, Estrogen research, The great estrogen conundrum, Science 302 (2003), 1136-1138.
30. S.R. Datta, A. Brunet and M.E. Greenberg, Cellular survival: a play in three Akts, Genes Dev 13 (1999), 2905-2927.
31. J.F. Disterhoft, W.W. Wu and M. Ohno, Biophysical alterations of hippocampal pyramidal neurons in learning, ageing and Alzheimer's disease, Ageing Res Rev 3 (2004), 383-406.
32. G.P. Dohanich, Gonadal steroids, learning and memory, in: Hormones, Brain and Behavior, R.T. Rubin, ed., Academic Press, San Diego, 2002, pp. 265-327.
33. D.B. Dubal, H. Zhu, J. Yu, S.W. Rau, P.J. Shughrue, I. Merchenthaler, M.S. Kindy and P.M. Wise, Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury, Proc Natl Acad Sci USA 98 (2001), 1952-1957.
34. 2+-dependent processes: relation to hippocampal synaptic plasticity, Hippocampus 7 (1997), 602-612.
35. T.C. Foster, Involvement of hippocampal synaptic plasticity in age-related memory decline, Brain Res Rev 30 (1999), 236-249.
36. M. Foy, M. Baudry and R. Thompson, Estrogen and hippocampal synaptic plasticity, Neuron Glia Biol 1 (2004), 327-338.
37. M.R. Foy, Neuromodulation: Effects of estradiol and THC on brain excitability, Doctoral Dissertation, Kent State University, Kent, OH, 1983.
38. M.R. Foy and T.J. Teyler, 17-alpha-Estradiol and 17-beta-estradiol in hippocampus, Brain Res Bull 10 (1983), 735-739.
39. M.R. Foy, J. Xu, X. Xie, R.D. Brinton, R.F. Thompson and T.W. Berger, 17beta-estradiol enhances NMDA receptor-mediated EPSPs and long-term potentiation, J Neurophysiol 81 (1999), 925-929.
40. M.R. Foy, 17beta-estradiol: effect on CA1 hippocampal synaptic plasticity, Neurobiol Learn Mem 76 (2001), 239-252.
41. M.R. Foy, G. Akopian and R.F. Thompson, 17B-estradiol enhances LTP in hippocampal slices from 3xTg-AD mice, Soc Neurosci Abstr (2006), Program No. 536.515.
42. M.R. Foy, M. Baudry, J.G. Foy and R.F. Thompson, 17beta-estradiol modifies stress-induced and age-related changes in hippocampal synaptic plasticity, Behav Neurosci 122 (2008), 301-309.
43. L.A. Galea, M. Kavaliers, K.P. Ossenkopp and E. Hampson, Gonadal hormone levels and spatial learning performance in the Morris water maze in male and female meadow voles, Microtus pennsylvanicus, Horm Behav 29 (1995), 106-125.
44. A.H. Gazzaley, N.G. Weiland, B.S. McEwen and J.H. Morrison, Differential regulation of NMDAR1 mRNA and protein by estradiol in the rat hippocampus, J Neurosci 16 (1996), 6830-6838.
45. Y. Geinisman, F. Detoledo-Morell and R.E. Heller, Hippocampal markers of age-related memory dysfunction: behaivoral, electrophysiological and morphological perspectives, Prog Neurobiol 45 (1995), 223-252.
46. Y. Geinisman, Structural synaptic modifications associated with hippocampal LTP and behavioral learning, Cereb Cortex 10 (2000), 952-962.
47. R.B. Gibbs, D. Wu, L.B. Hersh and D.W. Pfaff, Effects of estrogen replacement on the relative levels of choline acetyltransferase, trkA, and nerve growth factor messenger RNAs in the basal forebrain and hippocampal formation of adult rats, Exp Neurol 129 (1994), 70-80.
48. L.M. Grover and T.J. Teyler, Two components of long-term potentiation induced by different patterns of afferent activation, Nature 347 (1990), 477-479.
49. Q. Gu and R.L. Moss, 17B-estradiol potentiates kainite-induced currents via activation of the camp cascade, J Neurosci 16 (1996), 3620-3629.
50. J. Hardy and D.J. Selkoe, The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics, Science 297 (2002), 353-356.
51. V.W. Henderson, Estrogen replacement therapy for the prevention and treatment of Alzheimer's disease, CNS Drugs 8 (1997), 343-351.
52. V.W. Henderson, Hormone Therapy and the Brain: A Clinical Perspective on the Role of Estrogen, Parthenon Publishing, New York, 2000.
53. V.W. Henderson, A. Paganini-Hill, B.L. Miller, R.J. Elble, P.F. Reyes, D. Shoupe, C.A. McCleary, R.A. Klein, A.M. Hake and M.R. Farlow, Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial, Neurology 54 (2000), 295-301.
54. V.W. Henderson, K.S. Benke, R.C. Green, L.A. Cupples and L.A. Farrer, Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age, J Neurol Neurosurg Psychiatry 76 (2005), 103-105.
55. C. Hirata-Fukae, H.F. Li, H.S. Hoe, A.J. Gray, S.S. Minami, K. Hamada, T. Niikura, F. Hua, H. Tsukagoshi-Nagai, Y. Horikoshi-Sakuraba, M. Mughal, G.W. Rebeck, F.M. LaFerla, M.P. Mattson, N. Iwata, T.C. Saido, W.L. Klein, K.E. Duff, P.S. Aisen and Y. Matsuoka, Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model, Brain Res 1216 (2008), 92-103.
56. L.X. Hy and D.M. Keller, Prevalence of AD among whites: a summary by levels of severity, Neurology 55 (2000), 198-204.
57. K. Ito, H. Utsunomiya, N. Yaegashi and H. Sasano, Biological roles of estrogen and progesterone in human endometrial carcinoma-new developments in potential endocrine therapy for endometrial cancer, Endocr J 54 (2007), 667-679.
58. Z. Jonasson, Meta-analysis of sex differences in rodent models of learning and memory: a review of behavioral and biological data, Neurosci Biobehav Rev 28 (2005), 811-825.
59. D.L. Kampen and B.B. Sherwin, Estrogen use and verbal memory in healthy postmenopausal women, Obstet Gynecol 83 (1994), 979-983.
60. C. Kawas, S. Resnick, A. Morrison, R. Brookmeyer, M. Corrada, A. Zonderman, C. Bacal, D.D. Lingle and E. Metter, A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging, Neurology 48 (1997), 1517-1521.
61. S.G. Kohama, J.R. Goss, C.E. Finch and T.H. McNeill, Increases of glial fibrillary acidic protein in the aging female mouse brain, Neurobiol Aging 16 (1995), 59-67.
62. P.W. Landfield and G. Lynch, Impaired monosynaptic potentiation in in vitro hippocampal slices from age, memory-deficient rats, J Gerontol 32 (1977), 523-533.
63. 2+ ratios on frequency potentiation in hip pocampal slices of young and aged rats, J Neurophysiol 56 (1986), 797-811.
64. P.W. Landfield and S.A. Deadwyler, Long-Term Potentiation: From Biophysics to Behavior, Alan R. Liss, Inc., New York, 1988.
65. S.J. Lee and B.S. McEwen, Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications, Ann Rev Pharmacol Toxicol 41 (2001), 569-591.
66. B. Leuner, S. Mendolia-Loffredo and T.J. Shors, High levels of estrogen enhance associative memory formation in ovariectomized females, Psychoneuroendocrinology 29 (2004), 883-890.
67. K. Matthews, J. Cauley, K. Yaffe and J.M. Zmuda, Estrogen replacement therapy and cognitive decline in older community women, J Am Geriatric Soc 47 (1999), 518-523.
68. C. Mazzucchelli and R. Brambilla, Ras-related and MAPK signaling in neuronal plasticity and memory function, Cell Molecular Life Science 57 (2000), 604-611.
69. B.S. McEwen, J. Gerlach and D. Micco, Putative glucocorticoid receptors in hippocampus and other regions of the rat brain, in: The Hippocampus, Vol 2: Neurophysiology and behavior, R. Isaacson and K. Pribram, eds., Plenum, New York, 1975.
70. B. McEwen and S.E. Alves, Estrogen actions in the central nervous system, Endocr Rev 20 (1999), 279-307.
71. B. McEwen, K. Akama, S. Alves, W.G. Brake, K. Bulloch, S. Lee, C. Li, G. Yuen and T.A. Milner, Tracking the estrogen receptor in neurons: implications for estrogen-induced synapse formation, Proc Natl Acad Sci USA 98 (2001), 7093-7100.
72. S.L. Morgan, C.M. Coussens and T.J. Teyler, Depotentiation of vdccLTP requires NMDAR activation, Neurobiol Learn Mem 76 (2001), 229-238.
73. R.A. Mulnard, C.W. Cotman, C. Kawas, C.H. van Dyck, M. Sano, R. Doody, E. Koss, E. Pfeiffer, S. Jin, A. Gamst, M. Grundman, R. Thomas and L.J. Thal, Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial, Alzheimer's Disease Cooperative Study, JAMA 283 (2000), 1007-1015.
74. D.D. Murphy, N.B. Cole, V. Greenberger and M. Segal, Estradiol increases dendritic spine density by reducing GABA neurotransmission in hippocampal neurons, J Neurosci 18 (1998), 2550-2559.
75. J. Nilsen and R.D. Brinton, Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxprogesterone acetate, Endocrinology 143 (2002), 205-212.
76. J. Nilsen and R.D. Brinton, Impact of progestins on estradiol potentiation of the glutamate calcium response, Neuroreport 13 (2002), 825-830.
77. J. Nilsen and R.D. Brinton, Divergent impact of progesterone and medroxyprogesterone acetate (Provera) on nuclear mitogen-activated protein kinase signaling, Proc Natl Acad Sci USA 100 (2003), 10506-10511.
78. C.M. Norris, D.L. Korol and Foster', Increased susceptibility to induction of long-term depression and long-term potentiation reversal during aging, J Neurosci 16 (1996), 5382-5392.
79. 2+ channels, J Neurosci 18 (1998), 3171-3179.
80. S. Oddo, A. Caccamo, J.D. Shepherd, M.P. Murphy, T.E. Golde, R. Kayed, R. Metherate, M.P. Mattson, Y. Akbari and F.M. LaFerla, Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction, Neuron 39 (2003), 409-421.
81. M.G. Packard and L.A. Teather, Posttraining estradiol injections enhance memory in ovariectomized rats: cholinergic blockade and synergism, Neurobiol Learn Mem 68 (1997), 172-188.
82. A. Paganini-Hill and V.W. Henderson, Estrogen deficiency and risk of Alzheimer's disease in women, Am J Epidemiol 140 (1994), 256-261.
83. A. Paganini-Hill and V.W. Henderson, Estrogen replacement therapy and risk of Alzheimer disease, Arch Intern Med 156 (1996), 2213-2217.
84. D.W. Pfaff and B.S. McEwen, Actions of estrogens and progestins on nerve cells, Science 219 (1983), 808-814.
85. J.M. Power, W.W. Wu, E. Sametsky, M.M. Oh and J.F. Disterhoft, Age-related enhancement of the slow outward calcium-activated potassium current in hippocampal CA1 pyramidal neurons in vitro, J Neurosci 22 (2002), 7234-7243.
86. J. Quevedo, M. Vianna, D. Daroit, A.G. Born, C.R. Kuyven, R. Roesler and J.A. Quillfeldt, L-type voltage-dependent calcium channel blocker nifedipine enhances memory retention when infused into the hippocampus, Neurobiol Learn Mem 69 (1998), 320-325.
87. S.R. Rapp, M.A. Espeland, S.A. Shumaker, V.W. Henderson, R.L. Brunner, J.E. Manson, M.L. Gass, M.L. Stefanick, D.S. Lane, J. Hays, K.C. Johnson, L.H. Coker, M. Dailey and D. Bowen, Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial, JAMA 289 (2003), 2663-2672.
88. S.M. Resnick and P.M. Maki, Effects of hormone replacement therapy on cognitive and brain aging, Ann NY Acad Sci 949 (2001), 203-214.
89. J.C. Selcher, C.M. Atkins, J.M. Trzaskos, R. Paylor and J.D. Sweatt, Anecessity for MAP kinase activation in mammalian spatial learning, Learn Mem 6 (1999), 478-490.
90. D.J. Selkoe, Alzheimer's disease: genes, proteins, and therapy, Physiol Rev 81 (2001), 741-766.
91. N. Shabani, I. Mylonas, U. Jeschke, A. Thaqi, C. Kuhn, T. Puchner and K. Friese, Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium, Anticancer Res 27 (2007), 2027-2033.
92. T.J. Shors and L.D. Matzel, Long-term potentiation: what's learning got to do with it? Brain Behav Sci 20 (1997), 597-614.
93. S.A. Shumaker, C. Legault, S.R. Rapp, L. Thal, R.B. Wallace, J.K. Ockene, S.L. Hendrix, B.N. Jones, 3rd, A.R. Assaf, R.D. Jackson, J.M. Kotchen, S. Wassertheil-Smoller and J. Wactawski-Wende, Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial, JAMA 289 (2003), 2651-2662.
94. T. Simoncini, A. Hafezi-Moghadam, D.P. Brazil, K. Ley, W.W. Chin and J.K. Liao, Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase, Nature 407 (2000), 538-541.
95. C.A. Singer, X.A. Figueroa-Masot, R.H. Batchelor and D.M. Dorsa, The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons, J Neurosci 19 (1999), 2455-2463.
96. C. Singh, J.M. Wang, B. Guerrero, R.D. Brinton and R.F. Thompson, Allopregnanolone reverses the learning and memory deficits in the triple transgenic Alzheimer disease mouse model, Soc Neurosci Abstr (2007), Program No. 49.10.
97. M. Singh, E.M. Meyer, W.J. Millard and J.W. Simpkins, Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats, Brain Res 644 (1994), 305-312.
98. M. Singh, G. Setalo, Jr., X. Guan, D.E. Frail and C.D. Toran-Allerand, Estrogen-induced activation of the mitogen-activated protein kinase cascade in the cerebral cortex of estrogen receptor-alpha knock-out mice, J Neurosci 20 (2000), 1694-1700.
99. M. Singh, N. Sumien, C. Kyser and J.W. Simpkins, Estrogens and progesterone as neuroprotectants: what animal models teach us, Front Biosci 13 (2008), 1083-1089.
100. L.R. Squire, C.E. Stark and R.E. Clark, The medial temporal lobe, Annu Rev Neurosci 27 (2004), 279-306.
101. S. Suzuki, C.M. Brown and P.M. Wise, Mechanisms of neuroprotection by estrogen, Endocrine 29 (2006), 209-215.
102. J.D. Sweatt, The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory, J Neurochem 76 (2001), 1-10.
103. K. Takehara, S. Kawahara and Y. Kirino, Time-dependent reorganization of the brain components underlying memory retention in trace eyeblink conditioning, J Neurosci 23 (2003), 9897-9905.
104. P. Tanapat, N.B. Hastings and E. Gould, Ovarian steroids influence cell proliferation in the dentate gyrus of the adult female rat in a dose- and time-dependent manner, J Comp Neurol 481 (2005), 252-265.
105. M.X. Tang, D. Jacobs, Y. Stern, K. Marder, P. Schofield, B. Gurland, H. Andrews and R. Mayeux, Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease, Lancet 348 (1996), 429-432.
106. E. Terasawa and P.S. Timiras, Electrical activity during the estrous cycle of the rat: cyclic changes in limbic structures, Endocrinology 83 (1968), 207-216.
107. T.J. Teyler, R.M. Vardaris, D. Lewis and A.B. Rawitch, Gonadal steroids: effects on excitability of hippocampal pyramidal cells, Science 209 (1980), 1017-1018.
108. C. Touma, O. Ambree, N. Gortz, K. Keyvani, L. Lewejohann, R. Palme, W. Paulus, K. Schwarze-Eicker and N. Sachser, Age- and sex-dependent development of adrenocortical hyperactivity in a transgenic mouse model of Alzheimer's disease, Neurobiol Aging 25 (2004), 893-904.
109. J.Q. Trojanowski and V.M. Lee, Phosphorylation of paired helical filament tau in Alzheimer's disease neurofibrillary lesions: focusing on phosphatases, FASEB J 9 (1995), 1570-1576.
110. R.M. Vardaris and T.J. Teyler, Sex differences in the response of hippocampal CA1 pyramids to gonadal steroids: Effects of testosterone and estradiol on the in vitro slice preparation, Soc Neurosci Abstr (1980), A153.159.
111. R.M. Vouimba, M.R. Foy and R.F. Thompson, 17B-estradiol suppresses expression of long-term depression in aged rats, Brain Res Bull 53 (2000), 783-787.
112. J.M. Wang, P.B. Johnston, B.G. Ball and R.D. Brinton, The neurosteroid allopregnanolone promotes proliferation of rodent and human neural progenitor cells and regulates cell-cycle gene and protein expression, J Neurosci 25 (2005), 4706-4718.
113. S.G. Warren, A.G. Humphreys, J.M. Juraska and W.T. Greenough, LTP varies across the estrous cycle: enhanced synaptic plasticity in proestrus rats, Brain Res 703 (1995), 26-30.
114. S.G. Warren and J.M. Juraska, Spatial and nonspatial learning across the rat estrous cycle, Behav Neurosci 111 (1997), 259-266.
115. P.M. Wise, D.B. Dubal, M.E. Wilson, S.W. Rau, M. Bottner and K.L. Rosewell, Estradiol is a protective factor in the adult and aging brain: understanding of mechanisms derived from in vivo and in vitro studies, Brain Res Brain Res Rev 37 (2001), 313-319.
116. M. Wong and R.L. Moss, Electrophysiological evidence for a rapid membrane action of the gonadal steroid, 17 betaestradiol, on CA1 pyramidal neurons of the rat hippocampus, Brain Res 543 (1991), 148-152.
117. M. Wong and R.L. Moss, Long-term and short-term electrophysiological effects of estrogen on the synaptic properties of hippocampal CA1 neurons, J Neurosci 12 (1992), 3217-3225.
118. M. Wong and R.L. Moss, Patch-clamp analysis of direct steroidal modulation of glutamate receptor-channels, J Neuroendocrinol 6 (1994), 347-355.
119. M. Wong, T.L. Thompson and R.L. Moss, Nongenomic actions of estrogens in the brain: physiological significance and cellular mechanisms, Crit Rev Neurobiol 10 (1996), 189-203.
120. C.S. Woolley and B.S. McEwen, Estradiol regulates hippocampal dendritic spine density via an N-methyl-Daspartate receptor-dependent mechanism, J Neurosci 14 (1994), 7680-7687.
121. C.S. Woolley, N.G. Weiland, B.S. McEwen and P.A. Schwartzkroin, Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: correlation with dendritic spine density, J Neurosci 17 (1997), 1848-1859.
122. C.S. Woolley, Estrogen-mediated structural and functional synaptic plasticity in the female rat hippocampus, Horm Behav 34 (1998), 140-148.
123. 2+ influx via L-type calcium channels activates the Src/ERK/cyclic-AMP response element binding protein signal pathway and BCL-2 expression in rat hippocampal neurons: a potential initiation mechanism for estrogen-induced neuroprotection, Neuroscience 135 (2005), 59-72.
124. X. Xie, T.W. Berger and G. Barrionuevo, Isolated NMDA receptor-mediated synaptic responses express both LTP and LTD, J Neurophysiol 67 (1992), 1009-1013.
125. R.F. Zec and M.A. Trivedi, The effects of estrogen replacement therapy on neuropsychological functioning in postmenopausal women with and without dementia: a critical and theoretical review, Neuropsychol Rev 12 (2002), 65-109.
126. Y. Zeng, M.R. Foy, T.J. Teyler and R.F. Thompson, 17B-estradiol enhancement of nmda LTP in hippocampus, Soc Neurosci Abstr (2004), Program No. 972.972.